SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Valerio Nobili, Benedetta Donati, Nadia Panera, Apirom Vongsakulyanon, Anna Alisi, Bruno Dallapiccola, Luca Valenti, A 4-Polymorphism Risk Score Predicts Steatohepatitis in Children With Nonalcoholic Fatty Liver Disease, Journal of Pediatric Gastroenterology and Nutrition, 2014, 58, 5, 632

    CrossRef

  2. 2
    A. Viitasalo, J. Pihlajamaki, V. Lindi, M. Atalay, D. Kaminska, R. Joro, T. A. Lakka, Associations of I148M variant in PNPLA3 gene with plasma ALT levels during 2-year follow-up in normal weight and overweight children: the PANIC Study, Pediatric Obesity, 2014, 9, 4
  3. 3
    S. Petta, F. S. Macaluso, A. Craxi, Cardiovascular diseases and HCV infection: a simple association or more?, Gut, 2014, 63, 3, 369

    CrossRef

  4. 4
    Luca Valenti, Bruno Dallapiccola, Valerio Nobili, Genetic Insight Into the Pathogenesis of Nonalcoholic Fatty Liver Disease, Journal of Pediatric Gastroenterology and Nutrition, 2014, 58, 2, 139

    CrossRef

  5. 5
    Eylul Ece Islek, Ali Sazci, Mavi Deniz Ozel, Cem Aygun, Genetic Variants in thePNPLA3Gene Are Associated with Nonalcoholic Steatohepatitis, Genetic Testing and Molecular Biomarkers, 2014, 140515123756004

    CrossRef

  6. 6
    Raffaela Rametta, Massimiliano Ruscica, Paola Dongiovanni, Chiara Macchi, Anna L. Fracanzani, Liliana Steffani, Silvia Fargion, Paolo Magni, Luca Valenti, Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance, European Journal of Clinical Investigation, 2014, 44, 7
  7. 7
    Valerio Nobili, Daniela Liccardo, Giorgio Bedogni, Guglielmo Salvatori, Daniela Gnani, Iliana Bersani, Anna Alisi, Luca Valenti, Massimiliano Raponi, Influence of dietary pattern, physical activity, and I148M PNPLA3 on steatosis severity in at-risk adolescents, Genes & Nutrition, 2014, 9, 3

    CrossRef

  8. 8
    Hannele Yki-Järvinen, Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome, The Lancet Diabetes & Endocrinology, 2014,

    CrossRef

  9. 9
    J. Shen, G. L.-H. Wong, H. L.-Y. Chan, H.-Y. Chan, D. K.-W. Yeung, R. S.-M. Chan, A. M.-L. Chim, A. W.-H. Chan, P. C.-L. Choi, J. Woo, W. C.-W. Chu, V. W.-S. Wong, PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome, Alimentary Pharmacology & Therapeutics, 2014, 39, 5
  10. 10
    Vincent Zimmer, Frank Lammert, Role of genetics in diagnosis and therapy of acquired liver disease, Molecular Aspects of Medicine, 2014, 37, 15

    CrossRef

  11. 11
    Cristina Maglio, Carlo Pirazzi, Arturo Pujia, Luca Valenti, Stefano Romeo, The PNPLA3 I148M variant and chronic liver disease: When a genetic mutation meets nutrients, Food Research International, 2014, 63, 239

    CrossRef

  12. 12
    Ivana A. Stojkovic, Ulrika Ericson, Gull Rukh, Martin Riddestråle, Stefano Romeo, Marju Orho-Melander, The PNPLA3 Ile148Met interacts with overweight and dietary intakes on fasting triglyceride levels, Genes & Nutrition, 2014, 9, 2

    CrossRef

  13. 13
    Yang-Lin Liu, Helen L. Reeves, Alastair D. Burt, Dina Tiniakos, Stuart McPherson, Julian B. S. Leathart, Michael E. D. Allison, Graeme J. Alexander, Anne-Christine Piguet, Rodolphe Anty, Peter Donaldson, Guruprasad P. Aithal, Sven Francque, Luc Van Gaal, Karine Clement, Vlad Ratziu, Jean-Francois Dufour, Christopher P. Day, Ann K. Daly, Quentin M. Anstee, TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease, Nature Communications, 2014, 5,

    CrossRef

  14. 14
    Romy Kursawe, Nicola Santoro, 2014,

    CrossRef

  15. 15
    Valerio Nobili, Gianluca Svegliati-Baroni, Anna Alisi, Luca Miele, Luca Valenti, Pietro Vajro, A 360-degree overview of paediatric NAFLD: Recent insights, Journal of Hepatology, 2013, 58, 6, 1218

    CrossRef

  16. 16
    Bart G.P. Koot, Olga H. van der Baan-Slootweg, Anneloes E. Bohte, Aart J. Nederveen, Jochem R. van Werven, Christine L.J. Tamminga-Smeulders, Maruschka P. Merkus, Frank G. Schaap, Peter L.M. Jansen, Jaap Stoker, Marc A. Benninga, Accuracy of prediction scores and novel biomarkers for predicting nonalcoholic fatty liver disease in obese children, Obesity, 2013, 21, 3
  17. You have free access to this content17
    Ryan W. Walker, Frank Sinatra, Jaana Hartiala, Marc Weigensberg, Donna Spruijt-Metz, Tanya L. Alderete, Michael I. Goran, Hooman Allayee, Genetic and clinical markers of elevated liver fat content in overweight and obese hispanic children, Obesity, 2013, 21, 12
  18. 18
    Surya Prakash Bhatt, Priyanka Nigam, Anoop Misra, Randeep Guleria, Ravindra Mohan Pandey, M.A. Qadar Pasha, Genetic Variation in the Patatin-Like Phospholipase Domain-Containing Protein-3(PNPLA-3)Gene in Asian Indians with Nonalcoholic Fatty Liver Disease, Metabolic Syndrome and Related Disorders, 2013, 11, 5, 329

    CrossRef

  19. 19
    Marcin Krawczyk, Frank Grünhage, Frank Lammert, Identification of Combined Genetic Determinants of Liver Stiffness within the SREBP1c-PNPLA3 Pathway, International Journal of Molecular Sciences, 2013, 14, 10, 21153

    CrossRef

  20. 20
    Akinobu Takaki, Daisuke Kawai, Kazuhide Yamamoto, Multiple Hits, Including Oxidative Stress, as Pathogenesis and Treatment Target in Non-Alcoholic Steatohepatitis (NASH), International Journal of Molecular Sciences, 2013, 14, 10, 20704

    CrossRef

  21. 21
    Anna Alisi, Guido Carpino, Valerio Nobili, Paediatric nonalcoholic fatty liver disease, Current Opinion in Gastroenterology, 2013, 29, 3, 279

    CrossRef

  22. 22
    Mauro Viganò, Luca Valenti, Pietro Lampertico, Floriana Facchetti, Benedetta Maria Motta, Roberta D'Ambrosio, Solange Romagnoli, Paola Dongiovanni, Benedetta Donati, Silvia Fargion, Massimo Colombo, Patatin-like phospholipase domain-containing 3 I148M affects liver steatosis in patients with chronic hepatitis B, Hepatology, 2013, 58, 4
  23. 23
    Luca Valenti, Paola Dongiovanni, Stefano Ginanni Corradini, Maria Antonella Burza, Stefano Romeo, PNPLA3 I148M variant and hepatocellular carcinoma: A common genetic variant for a rare disease, Digestive and Liver Disease, 2013, 45, 8, 619

    CrossRef

  24. 24
    Céline Dubuquoy, Anne-Françoise Burnol, Marthe Moldes, PNPLA3, a genetic marker of progressive liver disease, still hiding its metabolic function?, Clinics and Research in Hepatology and Gastroenterology, 2013, 37, 1, 30

    CrossRef

  25. 25
    Yuki Moritou, Fusao Ikeda, Yoshiaki Iwasaki, Nobuyuki Baba, Kouichi Takaguchi, Tomonori Senoh, Takuya Nagano, Yasuto Takeuchi, Tetsuya Yasunaka, Hideki Ohnishi, Yasuhiro Miyake, Akinobu Takaki, Kazuhiro Nouso, Kazuhide Yamamoto, Predictive impact of polymorphism of PNPLA3 on HCC development after interferon therapy in Japanese patients with chronic hepatitis C, SpringerPlus, 2013, 2, 1, 251

    CrossRef

  26. 26
    Quentin M. Anstee, Christopher P. Day, The genetics of NAFLD, Nature Reviews Gastroenterology & Hepatology, 2013, 10, 11, 645

    CrossRef

  27. 27
    Valerio Nobili, Giorgio Bedogni, Benedetta Donati, Anna Alisi, Luca Valenti, The I148M Variant of PNPLA3 Reduces the Response to Docosahexaenoic Acid in Children with Non-Alcoholic Fatty Liver Disease, Journal of Medicinal Food, 2013, 16, 10, 957

    CrossRef

  28. 28
    Ajay Duseja, Rakesh Aggarwal, APOC3 and PNPLA3 in non-alcoholic fatty liver disease: Need to clear the air, Journal of Gastroenterology and Hepatology, 2012, 27, 5
  29. 29
    Pietro Vajro, Selvaggia Lenta, Piotr Socha, Anil Dhawan, Patrick McKiernan, Ulrich Baumann, Ozlem Durmaz, Florence Lacaille, Valerie McLin, Valerio Nobili, Diagnosis of Nonalcoholic Fatty Liver Disease in Children and Adolescents, Journal of Pediatric Gastroenterology and Nutrition, 2012, 54, 5, 700

    CrossRef

  30. 30
    Dawn M. Torres, Christopher D. Williams, Stephen A. Harrison, Features, Diagnosis, and Treatment of Nonalcoholic Fatty Liver Disease, Clinical Gastroenterology and Hepatology, 2012, 10, 8, 837

    CrossRef

  31. 31
    Momoka Otsuka, Yuki Uchida, Takumi Kawaguchi, Eitaro Taniguchi, Atsushi Kawaguchi, Shingo Kitani, Minoru Itou, Tetsuharu Oriishi, Tatsuyuki Kakuma, Suiko Tanaka, Minoru Yagi, Michio Sata, Fish to meat intake ratio and cooking oils are associated with hepatitis C virus carriers with persistently normal alanine aminotransferase levels, Hepatology Research, 2012, 42, 10
  32. 32
    Yiling Li, Chao Xing, Zhong Tian, Hung-Chih Ku, Genetic variant I148M in PNPLA3 is associated with the ultrasonography-determined steatosis degree in a Chinese population, BMC Medical Genetics, 2012, 13, 1, 113

    CrossRef

  33. 33
    Michael I. Goran, Ryan Walker, Hooman Allayee, Genetic-related and carbohydrate-related factors affecting liver fat accumulation, Current Opinion in Clinical Nutrition and Metabolic Care, 2012, 15, 4, 392

    CrossRef

  34. 34
    L. Valenti, A. Aghemo, A. F. Stättermayer, P. Maggioni, S. Nicola, B. M. Motta, M. G. Rumi, P. Dongiovanni, P. Ferenci, M. Colombo, S. Fargion, Implications of PNPLA3 polymorphism in chronic hepatitis C patients receiving peginterferon plus ribavirin, Alimentary Pharmacology & Therapeutics, 2012, 35, 12
  35. 35
    Evelyn Hsu, Karen Murray, Is Nonalcoholic Fatty Liver Disease in Children the Same Disease as in Adults?, Clinics in Liver Disease, 2012, 16, 3, 587

    CrossRef

  36. 36
    Ajay K Duseja, It is Patatin-like Phospholipase Domain-containing 3 Gene (PNPLA3)—All the Way, Journal of Clinical and Experimental Hepatology, 2012, 2, 1, 94

    CrossRef

  37. 37
    Luca Valenti, Benedetta Maria Motta, Anna Alisi, Rita Sartorelli, Giulia Buonaiuto, Paola Dongiovanni, Raffaela Rametta, Serena Pelusi, Silvia Fargion, Valerio Nobili, LPIN1 rs13412852 Polymorphism in Pediatric Nonalcoholic Fatty Liver Disease, Journal of Pediatric Gastroenterology and Nutrition, 2012, 54, 5, 588

    CrossRef

  38. 38
    Anna Alisi, Stefano Cianfarani, Melania Manco, Carlo Agostoni, Valerio Nobili, Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: Pathogenetic role of genetic background and intrauterine environment, Annals of Medicine, 2012, 44, 1, 29

    CrossRef

  39. 39
    Swastik Agrawal, Ajay K Duseja, Non-alcoholic Fatty Liver Disease: East Versus West, Journal of Clinical and Experimental Hepatology, 2012, 2, 2, 122

    CrossRef

  40. 40
    Claudia Della Corte, Anna Alisi, Alessia Saccari, Rita De Vito, Andrea Vania, Valerio Nobili, Nonalcoholic Fatty Liver in Children and Adolescents: An Overview, Journal of Adolescent Health, 2012, 51, 4, 305

    CrossRef

  41. 41
    Carlo Pirazzi, Martin Adiels, Maria Antonella Burza, Rosellina Margherita Mancina, Malin Levin, Marcus Ståhlman, Marja-Riitta Taskinen, Marju Orho-Melander, Jeanna Perman, Arturo Pujia, Linda Andersson, Cristina Maglio, Tiziana Montalcini, Olov Wiklund, Jan Borén, Stefano Romeo, Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro, Journal of Hepatology, 2012, 57, 6, 1276

    CrossRef

  42. You have free access to this content42
    Stavra A. Xanthakos, Rohit Kohli, Pediatric nonalcoholic fatty liver disease: Prevalence, diagnosis, risk factors, and management, Clinical Liver Disease, 2012, 1, 4
  43. 43
    Karolina Rembeck, Cristina Maglio, Martin Lagging, Peer Christensen, Martti Färkkilä, Nina Langeland, Mads Buhl, Court Pedersen, Kristine Mørch, Gunnar Norkrans, Kristoffer Hellstrand, Magnus Lindh, Carlo Pirazzi, Maria Burza, Stefano Romeo, Johan Westin, PNPLA 3 I148M genetic variant associates with insulin resistance and baseline viral load in HCV genotype 2 but not in genotype 3 infection, BMC Medical Genetics, 2012, 13, 1, 82

    CrossRef

  44. 44
    Maria Antonella Burza, Carlo Pirazzi, Cristina Maglio, Kajsa Sjöholm, Rosellina Margherita Mancina, Per-Arne Svensson, Peter Jacobson, Martin Adiels, Marco Giorgio Baroni, Jan Borén, Stefano Ginanni Corradini, Tiziana Montalcini, Lars Sjöström, Lena Mariana Susann Carlsson, Stefano Romeo, PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellular carcinoma in obese individuals, Digestive and Liver Disease, 2012, 44, 12, 1037

    CrossRef

  45. 45
    Luca Valenti, Raffaela Rametta, Massimiliano Ruscica, Paola Dongiovanni, Liliana Steffani, Benedetta Motta, Elena Canavesi, Anna Fracanzani, Enrico Mozzi, Giancarlo Roviaro, Paolo Magni, Silvia Fargion, The i148m Pnpla3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls, BMC Gastroenterology, 2012, 12, 1, 111

    CrossRef

  46. 46
    Stefano Ballestri, Amedeo Lonardo, Dante Romagnoli, Lucia Carulli, Luisa Losi, Christopher P. Day, Paola Loria, Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD, Liver International, 2012, 32, 8
  47. 47
    Alessio Aghemo, Understanding the Role of PNPLA3 Genetic Variants in Patients with Chronic Hepatitis C Infection, Digestive Diseases and Sciences, 2012, 57, 8, 1977

    CrossRef

  48. 48
    Luca Valenti, Anna Alisi, Valerio Nobili, Unraveling the genetics of fatty liver in obese children: Additive effect of P446L GCKR and I148M PNPLA3 polymorphisms, Hepatology, 2012, 55, 3
  49. 49
    Nicola Santoro, Clarence K. Zhang, Hongyu Zhao, Andrew J. Pakstis, Grace Kim, Romy Kursawe, Daniel J. Dykas, Allen E. Bale, Cosimo Giannini, Bridget Pierpont, Melissa M. Shaw, Leif Groop, Sonia Caprio, Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents, Hepatology, 2012, 55, 3
  50. 50
    Yu-Cheng Lin, Pi-Feng Chang, Fu-Chang Hu, Wei-Shiung Yang, Mei-Hwei Chang, Yen-Hsuan Ni, A Common Variant in the PNPLA3 Gene is a Risk Factor for Non-Alcoholic Fatty Liver Disease in Obese Taiwanese Children, The Journal of Pediatrics, 2011, 158, 5, 740

    CrossRef

  51. 51
    Lynne E. Wagenknecht, Nicholette D. Palmer, Donald W. Bowden, Jerome I. Rotter, Jill M. Norris, Julie Ziegler, Yii-Der I. Chen, Steven Haffner, Ann Scherzinger, Carl D. Langefeld, Association of PNPLA3 with non-alcoholic fatty liver disease in a minority cohort: the Insulin Resistance Atherosclerosis Family Study, Liver International, 2011, 31, 3
  52. 52
    Ann K Daly, Stefano Ballestri, Lucia Carulli, Paola Loria, Christopher P Day, Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease, Expert Review of Gastroenterology & Hepatology, 2011, 5, 2, 253

    CrossRef

  53. 53
    Quentin M. Anstee, Ann K. Daly, Christopher P. Day, Genetic modifiers of non-alcoholic fatty liver disease progression, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011, 1812, 11, 1557

    CrossRef

  54. 54
    Andrea Tannapfel, Helmut Denk, Hans-Peter Dienes, Cord Langner, Peter Schirmacher, Michael Trauner, Berenike Flott-Rahmel, Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease, Virchows Archiv, 2011, 458, 5, 511

    CrossRef

  55. 55
    R Christopher Harmon, Dina G Tiniakos, Curtis K Argo, Inflammation in nonalcoholic steatohepatitis, Expert Review of Gastroenterology & Hepatology, 2011, 5, 2, 189

    CrossRef

  56. 56
    Jérôme Boursier, Alexandre Louvet, Liver fibrogenesis and genetic factors, Clinics and Research in Hepatology and Gastroenterology, 2011, 35, S3

    CrossRef

  57. 57
    Rosalind A. Coleman, Douglas G. Mashek, Mammalian Triacylglycerol Metabolism: Synthesis, Lipolysis, and Signaling, Chemical Reviews, 2011, 111, 10, 6359

    CrossRef

  58. 58
    Silvia Sookoian, Carlos J. Pirola, Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease, Hepatology, 2011, 53, 6
  59. 59
    Luca Valenti, Massimo Colombo, Silvia Fargion, Modulation of the effect of PNPLA3 I148M mutation on steatosis and liver damage by alcohol intake in patients with chronic hepatitis C, Journal of Hepatology, 2011, 55, 6, 1470

    CrossRef

  60. 60
    Aijun Qiao, Jichao Liang, Yaojun Ke, Chenghong Li, Ying Cui, Lian Shen, Huabing Zhang, Anfang Cui, Xiaojun Liu, Changzheng Liu, Yong Chen, Yi Zhu, Youfei Guan, Fude Fang, Yongsheng Chang, Mouse patatin-like phospholipase domain-containing 3 influences systemic lipid and glucose homeostasis, Hepatology, 2011, 54, 2
  61. 61
    Luca Valenti, MariaGrazia Rumi, Enrico Galmozzi, Alessio Aghemo, Benedetta Del Menico, Stella De Nicola, Paola Dongiovanni, Marco Maggioni, Anna Ludovica Fracanzani, Raffaela Rametta, Massimo Colombo, Silvia Fargion, Patatin-Like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C, Hepatology, 2011, 53, 3
  62. 62
    Luca Valenti, Valerio Nobili, PNPLA3 I148M polymorphism and liver damage in obese children, The Journal of Pediatrics, 2011, 159, 5, 876

    CrossRef

  63. 63
    Edmondo Falleti, Carlo Fabris, Sara Cmet, Annarosa Cussigh, Davide Bitetto, Elisabetta Fontanini, Ezio Fornasiere, Sara Bignulin, Elisa Fumolo, Eleonora Bignulin, Mario Pirisi, Pierluigi Toniutto, PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence, Liver International, 2011, 31, 8
  64. 64
    Luca Valenti, Valerio Nobili, Ahmad Al-Serri, Raffaela Rametta, Julian B.S. Leathart, Marco A. Zappa, Paola Dongiovanni, Anna L. Fracanzani, Arianna Alterio, Giancarlo Roviaro, Ann K. Daly, Silvia Fargion, Christopher P. Day, The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver, Journal of Hepatology, 2011, 55, 6, 1409

    CrossRef

  65. 65
    Tao Cai, Jean-François Dufour, Beat Muellhaupt, Tilman Gerlach, Markus Heim, Darius Moradpour, Andreas Cerny, Raffaele Malinverni, Vincent Kaddai, Murielle Bochud, Francesco Negro, Pierre-Yves Bochud, Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis, Journal of Hepatology, 2011, 55, 3, 529

    CrossRef

  66. 66
    Jeffrey D. Browning, Jonathan C. Cohen, Helen H. Hobbs, Patatin-like phospholipase domain-containing 3 and the pathogenesis and progression of pediatric nonalcoholic fatty liver disease, Hepatology, 2010, 52, 4
  67. 67
    Masafumi Ono, Nobuto Okamoto, Toshiji Saibara, The latest idea in NAFLD/NASH pathogenesis, Clinical Journal of Gastroenterology, 2010, 3, 6, 263

    CrossRef

  68. 68
    Guruprasad P. Aithal, Kshaunish Das, Abhijit Chowdhury, Epidemiology of Nonalcoholic Fatty Liver Disease (NAFLD),